96 results on '"Celli, Bartolome R."'
Search Results
2. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
3. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience
4. COPD and multimorbidity: recognising and addressing a syndemic occurrence
5. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
6. Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
7. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients
8. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients
9. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort
10. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort
11. Sex differences between women and men with COPD: A new analysis of the 3CIA study
12. Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies
13. Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease
14. Supplementation with Qter® and Creatine improves functional performance in COPD patients on long term oxygen therapy
15. Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial
16. Effect of a single exacerbation on decline in lung function in COPD
17. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
18. Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD
19. Chronic obstructive pulmonary disease: hiding in plain sight, a Statement from the COPD Foundation Medical and Scientific Advisory Committee
20. Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study
21. Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial
22. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO
23. Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study
24. Prevention of Acute Exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline
25. Executive Summary: Prevention of Acute Exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline
26. A Novel Nonhuman Primate Model of Cigarette Smoke–Induced Airway Disease
27. Airflow reversibility and long-term outcomes in patients with COPD without comorbidities
28. A post hoc pooled analysis of exacerbations among US participants in randomized controlled trials of tiotropium
29. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: A pilot study
30. An Evidence-Based Estimate on the Size of the Potential Patient Pool for Lung Volume Reduction Surgery
31. Lung deflation and oxygen pulse in COPD: Results from the NETT randomized trial
32. Bronchodilator Reversibility in COPD
33. Lung Volume Reduction Therapies for Advanced Emphysema: An Update
34. THE AVAILABILITY AND TRENDS OF BLOOD EOSINOPHIL DATA IN A LARGE NETWORK OF US HEALTH SYSTEMS (IKANOS EOS PREVIEW STUDY)
35. PHARMACOLOGIC MANAGEMENT AND OUTCOMES OF PATIENTS ON NON-TRIPLE MAINTENANCE THERAPY HOSPITALIZED FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A US HEALTHCARE DATABASE ANALYSIS
36. Distance and Oxygen Desaturation During the 6-min Walk Test as Predictors of Long-term Mortality in Patients With COPD
37. Update on the Management of COPD
38. C-Reactive Protein Levels and Survival in Patients With Moderate to Very Severe COPD
39. The 6-Min Walk Distance, Peak Oxygen Uptake, and Mortality in COPD
40. Impact of COPD Exacerbations on Patient-Centered Outcomes
41. Air Travel and Respiratory Disease
42. Patología respiratoria y vuelos en avión
43. Markers of disease severity in chronic obstructive pulmonary disease
44. Post-bronchodilator spirometry in chronic obstructive pulmonary disease
45. Gender and COPD in Patients Attending a Pulmonary Clinic
46. Chronic respiratory failure after lung resection: the role of pulmonary rehabilitation
47. Prevalence of paradoxical bronchoconstriction after inhaled albuterol
48. A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease
49. 105 - Reabilitação pulmonar
50. POSTOPERATIVE PULMONARY COMPLICATIONS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.